Asset Details
Do you wish to reserve the book?
The impact of cannabis use disorder on urologic oncologic surgery morbidity, length of stay, and inpatient cost: analysis of the National Inpatient Sample from 2003 to 2014
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The impact of cannabis use disorder on urologic oncologic surgery morbidity, length of stay, and inpatient cost: analysis of the National Inpatient Sample from 2003 to 2014
Do you wish to request the book?
The impact of cannabis use disorder on urologic oncologic surgery morbidity, length of stay, and inpatient cost: analysis of the National Inpatient Sample from 2003 to 2014
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The impact of cannabis use disorder on urologic oncologic surgery morbidity, length of stay, and inpatient cost: analysis of the National Inpatient Sample from 2003 to 2014
2024
Overview
Purpose
This study examined the impact of cannabis use disorder (CUD) on inpatient morbidity, length of stay (LOS), and inpatient cost (IC) of patients undergoing urologic oncologic surgery.
Methods
The National Inpatient Sample (NIS) from 2003 to 2014 was analyzed for patients undergoing prostatectomy, nephrectomy, or cystectomy (
n
= 1,612,743). CUD was identified using ICD-9 codes. Complex-survey procedures were used to compare patients with and without CUD. Inpatient major complications, high LOS (4th quartile), and high IC (4th quartile) were examined as endpoints. Univariable and multivariable analysis (MVA) were performed to compare groups.
Results
The incidence of CUD increased from 51 per 100,000 admissions in 2003 to 383 per 100,000 in 2014 (
p
< 0.001). Overall, 3,503 admissions had CUD. Patients with CUD were more frequently younger (50 vs. 61), male (86% vs. 78.4%), Black (21.7% vs. 9.2%), and had 1st quartile income (36.1% vs. 20.6%); all
p
< 0.001. CUD had no impact on any complication rates (all
p
> 0.05). However, CUD patients had higher LOS (3 vs. 2 days;
p
< 0.001) and IC ($15,609 vs. $12,415; p < 0.001). On MVA, CUD was not an independent predictor of major complications (
p
= 0.6). Conversely, CUD was associated with high LOS (odds ratio (OR) 1.31; 95% CI 1.08–1.59) and high IC (OR 1.33; 95% CI 1.12–1.59), both
p
< 0.01.
Conclusion
The incidence of CUD at the time of urologic oncologic surgery is increasing. Future research should look into the cause of our observed phenomena and how to decrease LOS and IC in CUD patients.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
/ Aged
/ Cannabis
/ Female
/ Humans
/ Male
/ Marijuana Abuse - epidemiology
/ Medicine
/ Oncology
/ Postoperative Complications - economics
/ Postoperative Complications - epidemiology
/ Surgery
/ United States - epidemiology
/ Urologic Neoplasms - economics
/ Urologic Neoplasms - surgery
/ Urologic Surgical Procedures - economics
/ Urology
